John Patrick Shannon Jr insider trades

Open-market stock purchases and sales by John Patrick Shannon Jr, See Remarks at Xeris Biopharma Holdings, Inc, from SEC Form 4 filings since Feb 12, 2013.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +139%.

Recent trades

DateStockTradeValue
Aug 1, 2026XERS Xeris Biopharma Holdings, IncSold (not open market)$296K
Jan 31, 2026XERS Xeris Biopharma Holdings, IncSold (not open market)$869K
Jan 31, 2026XERS Xeris Biopharma Holdings, IncSold (not open market)$822K
Jan 31, 2026XERS Xeris Biopharma Holdings, IncSold (not open market)$815K
Jan 30, 2026XERS Xeris Biopharma Holdings, IncBought (not open market)—
Jan 30, 2026XERS Xeris Biopharma Holdings, IncBought (not open market)—
Jan 5, 2026XERS Xeris Biopharma Holdings, IncBought (not open market)—
Jan 5, 2026XERS Xeris Biopharma Holdings, IncBought (not open market)—
Jan 5, 2026XERS Xeris Biopharma Holdings, IncSold$176K
Jan 5, 2026XERS Xeris Biopharma Holdings, IncBought (not open market)—
Nov 14, 2025XERS Xeris Biopharma Holdings, IncBought (not open market)—
Nov 13, 2025XERS Xeris Biopharma Holdings, IncSold$173K
Nov 13, 2025XERS Xeris Biopharma Holdings, IncBought (not open market)—

Companies traded

  • XERS Xeris Biopharma Holdings, Inc: 6 buys, 2 sales, last Aug 1, 2026
  • DRTX Durata Therapeutics, Inc: 1 buy, last Nov 17, 2014

Get free alerts when John Patrick Shannon Jr files a new trade →